Acute lymphoblastic leukemia and Paranasal sinus hypersecretion


Paranasal sinus hypersecretion is reported only by a few people with Acute lymphoblastic leukemia.

The study analyzes which people have Paranasal sinus hypersecretion with Acute lymphoblastic leukemia. It is created by eHealthMe based on 1 person who has Paranasal sinus hypersecretion and Acute lymphoblastic leukemia from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 03, 2022

1 person who has Acute Lymphoblastic Leukemia and Paranasal Sinus Hypersecretion is studied.

What is Acute lymphoblastic leukemia?

Acute lymphoblastic leukemia (cancer of the white blood cells characterized by excess lymphoblasts) is found to be associated with 972 drugs and 752 conditions by eHealthMe.

What is Paranasal sinus hypersecretion?

Paranasal sinus hypersecretion is found to be associated with 703 drugs and 386 conditions by eHealthMe.

Number of Paranasal sinus hypersecretion in Acute lymphoblastic leukemia reports submitted per year:

Would you have Paranasal sinus hypersecretion when you have Acute lymphoblastic leukemia?

Common co-existing conditions for these people *:

  1. Gastric Cancer (stomach cancer): 1 person, 100.00%

Common drugs taken by these people *:

  1. Tibsovo: 1 person, 100.00%
  2. Ritalin: 1 person, 100.00%
  3. Prozac: 1 person, 100.00%
  4. Pantoprazole: 1 person, 100.00%
  5. Cod Liver Oil: 1 person, 100.00%
  6. Armour Thyroid: 1 person, 100.00%

Common symptoms for these people *:

  1. Nausea And Vomiting: 1 person, 100.00%
  2. Impaired Work Ability: 1 person, 100.00%
  3. Fatigue (feeling of tiredness): 1 person, 100.00%
  4. Chills (felling of cold): 1 person, 100.00%
  5. Abdominal Pain: 1 person, 100.00%
  6. Abdominal Discomfort: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Paranasal sinus hypersecretion?

Check whether Paranasal sinus hypersecretion is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Paranasal sinus hypersecretion:

Common drugs associated with Paranasal sinus hypersecretion:

All the drugs that are associated with Paranasal sinus hypersecretion:

Common conditions associated with Paranasal sinus hypersecretion:

All the conditions that are associated with Paranasal sinus hypersecretion:

How the study uses the data?

The study is based on Paranasal sinus hypersecretion and Acute lymphoblastic leukemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: